Carregant...
Still the Great Debate – "Fair Balance" in Direct-to-Consumer Prescription Drug Advertising: Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters"
The above titled paper examined the Food and Drug Administration’s (FDA’s) warning letters and notice of violations (NOV) over a 10-year period. Findings from this content analysis reinforced what has been the primary issue for prescription direct-to-consumer advertising (DTCA) since its beginning,...
Guardat en:
| Publicat a: | Int J Health Policy Manag |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Kerman University of Medical Sciences
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4818998/ https://ncbi.nlm.nih.gov/pubmed/27239875 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15171/ijhpm.2016.17 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|